Neovacs (XPAR:ALNEV) Beginning Cash Position : €6.19 Mil (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Neovacs Beginning Cash Position?

Neovacs's Beginning Cash Position for the quarter that ended in Dec. 2023 was €6.19 Mil.

Neovacs's quarterly Beginning Cash Position declined from Dec. 2022 (€33.00 Mil) to Jun. 2023 (€7.09 Mil) and declined from Jun. 2023 (€7.09 Mil) to Dec. 2023 (€6.19 Mil).

Neovacs's annual Beginning Cash Position increased from Dec. 2021 (€10.07 Mil) to Dec. 2022 (€33.11 Mil) but then declined from Dec. 2022 (€33.11 Mil) to Dec. 2023 (€7.09 Mil).

Neovacs Beginning Cash Position Historical Data

The historical data trend for Neovacs's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neovacs Beginning Cash Position Chart

Neovacs Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

1.42

1.30

10.07

33.11

7.09

Neovacs Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Beginning Cash Position	Get a 7-Day Free Trial															35.79	33.10	33.00	7.09	6.19

Neovacs Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Neovacs Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Neovacs's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Neovacs (XPAR:ALNEV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neovacs SA (XPAR:ALNEV) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

0LWA:Germany

Address

3-5, Impasse Reille, Paris, FRA, 75014

Website

http://www.neovacs.fr

Neovacs SA is a biotechnology company focused on the development of "Kinoids", therapeutic vaccines for the treatment of autoimmune, inflammatory diseases, allergies and cancer.

Neovacs (XPAR:ALNEV) Headlines

No Headlines